HK1186176A1 - 甘氨酸衍生物及其醫藥組合物 - Google Patents
甘氨酸衍生物及其醫藥組合物Info
- Publication number
- HK1186176A1 HK1186176A1 HK13113602.8A HK13113602A HK1186176A1 HK 1186176 A1 HK1186176 A1 HK 1186176A1 HK 13113602 A HK13113602 A HK 13113602A HK 1186176 A1 HK1186176 A1 HK 1186176A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- receptor antagonists
- muscarinic receptor
- glycine derivatives
- glycine
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
- C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10192713 | 2010-11-26 | ||
PCT/EP2011/068894 WO2012069275A1 (en) | 2010-11-26 | 2011-10-27 | Glycine derivatives and their use as muscarinic receptor antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1186176A1 true HK1186176A1 (zh) | 2014-03-07 |
Family
ID=43608596
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK13113602.8A HK1186176A1 (zh) | 2010-11-26 | 2013-12-06 | 甘氨酸衍生物及其醫藥組合物 |
Country Status (10)
Country | Link |
---|---|
US (1) | US8772314B2 (zh) |
EP (1) | EP2643295B1 (zh) |
KR (1) | KR20130141534A (zh) |
CN (1) | CN103221390B (zh) |
AR (1) | AR083991A1 (zh) |
BR (1) | BR112013012160A2 (zh) |
CA (1) | CA2820600A1 (zh) |
HK (1) | HK1186176A1 (zh) |
RU (1) | RU2585767C2 (zh) |
WO (1) | WO2012069275A1 (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2862008A1 (en) | 2011-12-30 | 2013-07-04 | Chiesi Farmaceutici S.P.A. | Quinuclidine esters of 1-azaheterocyclylacetic acid as antimuscarinic agents, process for their preparation and medicinal compositions thereof |
RU2015121044A (ru) * | 2012-12-05 | 2017-01-12 | КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. | Производные фенилэтилпиридина в качестве ингибиторов pde4 |
RU2688191C2 (ru) | 2014-05-12 | 2019-05-21 | ВЕРОНА ФАРМА ПиэЛСи | Новое лечение |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2182568A1 (en) * | 1994-02-10 | 1995-08-17 | Makoto Takeuchi | Novel carbamate derivative and medicinal composition containing the same |
JP3555876B2 (ja) * | 1997-08-22 | 2004-08-18 | エフ.ホフマン−ラ ロシュ アーゲー | N−アロイルフェニルアラニン誘導体 |
KR100869722B1 (ko) | 2000-12-22 | 2008-11-21 | 알미랄 에이쥐 | 퀴누클리딘 카르바메이트 유도체 및 m3 길항제로서 그의사용 |
EP1461336B1 (en) | 2001-12-20 | 2013-05-22 | CHIESI FARMACEUTICI S.p.A. | 1-alkyl-1-azoniabicyclo (2.2.2) octane carbamate derivatives and their use as muscarinic receptor antagonists |
EP1882691A1 (en) | 2006-07-26 | 2008-01-30 | CHIESI FARMACEUTICI S.p.A. | Quinuclidine derivatives as M3 antagonists |
EP2154136A1 (en) | 2008-08-08 | 2010-02-17 | CHIESI FARMACEUTICI S.p.A. | Quinuclidine carbonate derivatives and medicinal compositions thereof |
EP2206712A1 (en) | 2008-12-23 | 2010-07-14 | CHIESI FARMACEUTICI S.p.A. | "Alkaloid aminoester derivatives and medicinal composition thereof" |
CN102947298B (zh) | 2010-06-22 | 2016-03-02 | 奇斯药制品公司 | 生物碱氨基酯衍生物及其药物组合物 |
BR112012032332A2 (pt) | 2010-06-22 | 2016-11-08 | Chiesi Farma Spa | composto, uso de um composto, composição farmacêutica, combinação de um composto e dispositivo |
RU2567548C2 (ru) | 2010-06-22 | 2015-11-10 | КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. | Производные сложного аминоэфира алкалоида и их лекарственные композиции |
-
2011
- 2011-10-27 WO PCT/EP2011/068894 patent/WO2012069275A1/en active Application Filing
- 2011-10-27 RU RU2013123694/04A patent/RU2585767C2/ru not_active IP Right Cessation
- 2011-10-27 CA CA2820600A patent/CA2820600A1/en not_active Abandoned
- 2011-10-27 BR BR112013012160A patent/BR112013012160A2/pt not_active IP Right Cessation
- 2011-10-27 EP EP11785359.8A patent/EP2643295B1/en active Active
- 2011-10-27 KR KR1020137012805A patent/KR20130141534A/ko not_active Application Discontinuation
- 2011-10-27 CN CN201180056178.2A patent/CN103221390B/zh not_active Expired - Fee Related
- 2011-11-23 US US13/303,413 patent/US8772314B2/en not_active Expired - Fee Related
- 2011-11-24 AR ARP110104393A patent/AR083991A1/es unknown
-
2013
- 2013-12-06 HK HK13113602.8A patent/HK1186176A1/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR20130141534A (ko) | 2013-12-26 |
AR083991A1 (es) | 2013-04-10 |
CA2820600A1 (en) | 2012-05-31 |
EP2643295B1 (en) | 2016-04-13 |
US8772314B2 (en) | 2014-07-08 |
CN103221390A (zh) | 2013-07-24 |
BR112013012160A2 (pt) | 2019-09-24 |
US20120134934A1 (en) | 2012-05-31 |
RU2585767C2 (ru) | 2016-06-10 |
WO2012069275A1 (en) | 2012-05-31 |
EP2643295A1 (en) | 2013-10-02 |
CN103221390B (zh) | 2015-06-03 |
RU2013123694A (ru) | 2014-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1188211A1 (zh) | 受體拮抗劑 | |
ZA201207259B (en) | 4-aminopyrimidine derivatives and their as as adenosine 121 receptor antagonists | |
ZA201307115B (en) | Androgen receptor antagonists and uses thereof | |
EP2585064A4 (en) | C5aR Antagonist | |
IL221241A0 (en) | Folate receptor 1 antibodies and immunoconjugates and uses thereof | |
IL232949A (en) | Methods and Compounds Used in the Synthesis of Orxin-2 Antagonist Receptor | |
ZA201202029B (en) | Androgen receptor antagonists and uses thereof | |
IL221620A (en) | Antagonist antibodies against the interleukin receptor 7 and methods for their use | |
IL215690A0 (en) | Thiazole derivatives and their use as p2y12 receptor antagonists | |
DK2821407T3 (da) | Piperidinoncarboxamidazaindan-cgrp receptorantagonister | |
EP2665707A4 (en) | Mineralocorticoid receptor antagonists | |
EP2619204A4 (en) | TRIAZOLOPYRAZINONES AS ANTAGONISTS OF P2X7 RECEPTORS | |
EP2582715A4 (en) | GROWTH HORMONE SECRETAGOGUE RECEPTOR ANTAGONISTS AND USES THEREOF | |
EP2617717A4 (en) | ANTAGONIST OF P2X4 RECEIVER | |
EP2765860A4 (en) | Mineralocorticoid receptor antagonists | |
EP2697203A4 (en) | ANTAGONISTS OF MINERALOCORTICOID RECEPTORS | |
EP2765859A4 (en) | Mineralocorticoid receptor antagonists | |
EP2610619A4 (en) | HEMOCININE-1 RECEPTOR AND HEMOCININE-1-PEPTIDE | |
EP2549872A4 (en) | TRPV4 Antagonist | |
EP2566494A4 (en) | CXCR4 RECEPTOR COMPOUNDS | |
IL241743A0 (en) | Non-competitive nicotinic receptor antagonists | |
EP2539706A4 (en) | ARYLPIPERAZONE ANTAGONISTS OF OPIOID RECEPTORS | |
HK1182097A1 (zh) | 受體拮抗劑 | |
HK1186176A1 (zh) | 甘氨酸衍生物及其醫藥組合物 | |
EP2765858A4 (en) | ANTAGONISTS OF A MINERALOCORTICOID RECEPTOR |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20191025 |